X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (90) 90
Newspaper Article (48) 48
Book Chapter (8) 8
Publication (8) 8
Book / eBook (4) 4
Conference Proceeding (4) 4
Dissertation (4) 4
Patent (3) 3
Book Review (2) 2
Video Recording (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (54) 54
oncology (40) 40
index medicus (30) 30
female (29) 29
middle aged (25) 25
aged (24) 24
male (23) 23
lung neoplasms - pathology (15) 15
adult (14) 14
carcinoma (13) 13
carcinoma, non-small-cell lung - pathology (12) 12
prognosis (12) 12
treatment outcome (12) 12
breast-cancer (10) 10
cancer (10) 10
chemotherapy (10) 10
expression (10) 10
respiratory system (10) 10
lung cancer (9) 9
survival (9) 9
cell line, tumor (8) 8
hematology, oncology and palliative medicine (8) 8
lung neoplasms - metabolism (8) 8
surgery (8) 8
adenocarcinoma - pathology (7) 7
aged, 80 and over (7) 7
antineoplastic agents - therapeutic use (7) 7
antineoplastic combined chemotherapy protocols - therapeutic use (7) 7
carcinoma, non-small-cell lung - diagnosis (7) 7
carcinoma, non-small-cell lung - drug therapy (7) 7
immunohistochemistry (7) 7
neoplasm staging (7) 7
non-small cell lung cancer (7) 7
pathology (7) 7
survival analysis (7) 7
analysis (6) 6
angiogenesis (6) 6
animals (6) 6
cancer research (6) 6
carcinoma, non-small-cell lung - metabolism (6) 6
carcinoma, squamous cell - pathology (6) 6
disability (6) 6
investigations (6) 6
lung neoplasms - diagnosis (6) 6
lung neoplasms - drug therapy (6) 6
lung neoplasms - mortality (6) 6
metastasis (6) 6
neoplasms - drug therapy (6) 6
non-small-cell lung cancer (6) 6
sex crimes (6) 6
survival rate (6) 6
therapy (6) 6
tumors (6) 6
wine (6) 6
adenocarcinoma (5) 5
carcinoma, non-small-cell lung - blood supply (5) 5
consensus (5) 5
disease progression (5) 5
esmo (5) 5
follow-up studies (5) 5
lung neoplasms - blood supply (5) 5
neoplasm invasiveness (5) 5
pharmacology & pharmacy (5) 5
proteins (5) 5
tumor angiogenesis (5) 5
antineoplastic agents - adverse effects (4) 4
apoptosis (4) 4
biochemistry (4) 4
carcinoma, non-small-cell lung - surgery (4) 4
cardiology and cardiovascular medicine (4) 4
care and treatment (4) 4
cell lung-cancer (4) 4
combined modality therapy (4) 4
development and progression (4) 4
disease-free survival (4) 4
gene expression regulation, neoplastic (4) 4
growth (4) 4
kaplan-meier estimate (4) 4
lung neoplasms - surgery (4) 4
medicine (4) 4
monoclonal-antibody (4) 4
neoplasms - pathology (4) 4
neovascularization, pathologic - pathology (4) 4
phase-ii trial (4) 4
pneumonectomy (4) 4
pulmonary and respiratory medicine (4) 4
adenocarcinoma - mortality (3) 3
adenocarcinoma - therapy (3) 3
alk (3) 3
analysis of variance (3) 3
antineoplastic agents - administration & dosage (3) 3
antineoplastic agents - pharmacokinetics (3) 3
area under curve (3) 3
article (3) 3
beer (3) 3
biomarkers (3) 3
biomarkers, tumor - metabolism (3) 3
biomedicine (3) 3
breast neoplasms - metabolism (3) 3
breast neoplasms - pathology (3) 3
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 5, pp. 577 - 589
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 11/2017, Volume 12, Issue 11, pp. 1626 - 1635
Journal Article
Asia‐Pacific Journal of Clinical Oncology, ISSN 1743-7555, 08/2016, Volume 12, Issue S4, pp. 3 - 3
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2003, Volume 21, Issue 21, pp. 3955 - 3964
Journal Article
CANCERS, ISSN 2072-6694, 05/2019, Volume 11, Issue 5, p. 620
Identifying and targeting specific oncogenic drivers has become standard of care in the routine management of patients with lung cancer. Research is ongoing to... 
non-small cell lung cancer | rearranged during transfection | MULTICENTER | GENE | ONCOLOGY | ALECTINIB | CRIZOTINIB | OPEN-LABEL | PHASE-2 | RET PROTOONCOGENE | CHEMOTHERAPY | RET fusions
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2018, Volume 36, Issue 15_suppl, pp. e21027 - e21027
Journal Article
Journal of Thoracic and Cardiovascular Surgery, The, ISSN 0022-5223, 2012, Volume 143, Issue 5, pp. 1130 - 1137.e1
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2014, Volume 9, Issue 6, p. e100816
The prognosis of epithelial ovarian cancer is poor in part due to the high frequency of chemoresistance. Recent evidence points to the Toll-like receptor-4... 
STEM-CELLS | MULTIDISCIPLINARY SCIENCES | TOLL-LIKE RECEPTORS | RESISTANCE | CHEMORESISTANCE | DIFFERENTIATION | NF-KAPPA-B | TUMOR-GROWTH | EXPRESSION | CARCINOMA | BREAST | Immunohistochemistry | RNA, Small Interfering - genetics | Paclitaxel - pharmacology | Prognosis | Neoplastic Stem Cells - drug effects | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | MicroRNAs - metabolism | Cystadenocarcinoma, Serous - genetics | Ovarian Neoplasms - mortality | Cystadenocarcinoma, Serous - drug therapy | Ovarian Neoplasms - genetics | Neoplasms, Glandular and Epithelial - genetics | Neoplasms, Glandular and Epithelial - mortality | Neoplastic Stem Cells - metabolism | Neoplastic Stem Cells - pathology | Female | Neoplasms, Glandular and Epithelial - diagnosis | Toll-Like Receptor 4 - antagonists & inhibitors | Ovarian Neoplasms - drug therapy | Signal Transduction | Ovarian Neoplasms - diagnosis | Myeloid Differentiation Factor 88 - genetics | Toll-Like Receptor 4 - genetics | Genotype | Toll-Like Receptor 4 - metabolism | Drug Resistance, Neoplasm - genetics | Phenotype | Neoplasms, Glandular and Epithelial - drug therapy | Survival Analysis | Carcinoma, Ovarian Epithelial | Cell Line, Tumor | Cystadenocarcinoma, Serous - mortality | Aged | MicroRNAs - genetics | Cystadenocarcinoma, Serous - diagnosis | Antineoplastic Agents, Phytogenic - pharmacology | Myeloid Differentiation Factor 88 - metabolism | RNA, Small Interfering - metabolism | MicroRNA | Analysis | Genetic aspects | Cell differentiation | Ovarian cancer | Health sciences | Transcription factors | Carcinoma | Ovarian carcinoma | Chemoresistance | Paraffin | Tissues | Cancer therapies | Proteins | Histopathology | Quality | Toll-like receptors | Tumor necrosis factor-TNF | Immune system | Mortality | Gynecology | MiRNA | Breast cancer | Functional analysis | TLR4 protein | Gene expression | Epithelium | Ribonucleic acid--RNA | Survival | Obstetrics | Pathology | Gene amplification | Chemotherapy | Hospitals | Womens health | MicroRNAs | Stem cells | MyD88 protein | Cancer | Tumors | RNA | Ribonucleic acid
Journal Article